CritiTech, Inc.: Clinical Trials

1 trial sponsored by CritiTech, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow CritiTech, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers
nanoparticulate paclitaxel - Peritoneal Neoplasms
Phase 1CompletedCritiTech, Inc.222008-07-012014-02-27

Conditions studied

Colonic Neoplasms (1)  ·  Digestive System Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Peritoneal Neoplasms (1)

Countries

United States (1)

Top investigators

Gary Johnson, M.D. (1)  ·  Julia Chapman, M.D. (1)  ·  Kathleen Moore, MD (1)  ·  Thomas K Schulz, M.D. (1)